Today, Novo Nordisk announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide injection 7.2 mg, to be used along with a reduced calorie diet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback